The chimeric tyrosine kinase p210 BCR ± ABL is involved in the pathogenesis of chronic myelogenous leukemia. It transforms immature hematopoietic cells in vitro and abrogates IL-3-dependent growth. The mechanisms by which p210 BCR ± ABL mediates its oncogenicity are not well elucidated. Identifying transcription factors targeted by the chimeric protein may help to clarify these mechanisms. We have analysed the eect of p210 BCR ± ABL expression on NF-kB activity in DA1 cells (an IL-3-dependent murine myeloid progenitor cell line). A speci®c stimulation of NF-kB activity by kinase-active wild-type p210 BCR ± ABL has been evidenced by transcriptional activation assays. Electrophoretic mobility supershift assays revealed the presence of p65 protein (RelA) DNA binding activity in p210 BCR ± ABL transformed DA1 cells but not in parental DA1 cells. Activation of RelA in transformed DA1 cells may occur by protein stabilization. Experiments using oligonucleotides antisense to RelA showed that p210 BCR ± ABL transfected cells failed to survive after IL-3 removal. Moreover, inhibition of cellular growth was shown following treatment of p210 BCR ± ABL transformed DA1 cells by p65 antisense oligonucleotides. This study suggests that p65 NF-kB may be an eector for p210 BCR ± ABL and probably contributes to its induced transformation process.
Introduction
Bcr ± abl is a chimeric oncogene generated by the reciprocal t(9;22)(q34;q11) translocation that fuses 5' bcr sequences upstream to the second exon of c-abl gene Heisterkamp et al., 1983; Rowley, 1973) . Depending on the breakpoint within bcr gene, two BCR ± ABL proteins can be generated, p185 and p210, which are associated with Acute Lymphoblastic Leukemia (ALL) and Chronic Myelogenous Leukemia (CML) respectively (reviewed in Kurzrock et al., 1988) . Both BCR ± ABL proteins possess deregulated Abl tyrosine kinase activity correlated with their transforming potency (Konopka et al., 1984; Lugo et al., 1990) .
P210 protein transforms immature hematopoietic cells in vitro and converts interleukin-3 (IL-3) dependent cell lines to growth factor independence (Daley and Baltimore, 1988; Mandanas et al., 1992) . It also cooperates with vMyc to fully transform Rat-1 ®broblasts (Lugo and Witte, 1989) .
The mechanisms by which p210 BCR ± ABL elicits its biological actions are not well understood. Activation of the Ras signaling cascade is an important component of BCR ± ABL mediated transformation (Mandanas et al., 1993; Sawyers et al., 1995) , and occurs after direct interaction of GRB-2 adapter protein with BCR ± ABL, or tyrosin phosphorylation of SHC adapter molecule by BCR ± ABL (Goga et al., 1995; Pendergast et al., 1993; Puil et al., 1994) . BCR ± ABL transformation also requires c-Myc (Sawyers et al., 1992) which may cooperate with Ras in two distinct signaling pathways to mediate this transformation (Afar et al., 1994) .
Studies using a temperature sensitive mutant of p210 BCR ± ABL have shown that the primary eect of p210 expression is to protect growth factor-dependent hematopoietic cells from cell death by apoptosis rather than delivering a proliferation signal (which is associated with growth factor independence/transformation) (Carlesso et al., 1994; Kabarowski et al., 1994) . The signaling components implicated in the antiapoptotic eect and the cellular transformation are likely distinct (Cortez et al., 1995) .
Although numerous proteins substrates of p210 BCR ± ABL are known (Daanhausser-Rield et al., 1996; Matsuguchi et al., 1995; Sattler et al., 1996; Shuai et al., 1996) , the mechanisms which underline the oncogenic activity of BCR ± ABL are not elucidated. Identifying the nuclear targets aected by p210 BCR ± ABL may help to understand these mechanisms. REL/NKkB is a family of pleiotropic transcription factors which are implicated in the regulation of numerous genes, such as those encoding cytokines/growth factors and cell adhesion molecules. REL/NF-kB is induced by a wide variety of stimuli including cytokines, physical and oxidative stresses, viruses and viral products. NFkB family contains several members which bind DNA as homodimers or heterodimers (p100-p50 (NF-kB1), p105-p52 (NF-kB2), c-Rel, p65 (RelA) and RelB). Regulation of REL/NF-kB family members occur at dierent levels and their activity is strictly controlled to mediate speci®c gene and cell responses (Brown et al., 1994; Dobzranski et al., 1994; Kunsch et al., 1992; Lernbecher et al., 1993; Liou and Baltimore, 1993; Naumann and Scheidereit, 1994; Perkins et al., 1992; Schmitz and Baeuerle, 1995) . REL/NF-kB proteins and their regulators IkB proteins have been associated with a number of viral and non viral malignancies (Gilmore et al., 1996) .
In this report we analysed whether REL/NF-kB proteins are targeted by p210 BCR ± ABL oncogene, using an IL-3 dependent murine myeloid cell line (DA1) as model system. Transcriptional activation assays showed a speci®c stimulation of NF-kB activity by p210 BCR ± ABL and thus further studies have been performed in order to identify which REL/NF-kB members are activated by p210 BCR ± ABL protein and at which level this activation occurs. Antisense oligonucleotides experiments suggested the involvement of this family in p210 BCR ± ABL mediated transformation.
Results

p210
BCR ± ABL increases NF-kB activity: transient assay
To test whether p210 BCR ± ABL expression aects NF-kB activity, we analysed the transcription of the cat reporter gene driven by a promoter harboring ®ve copies of the Igk kB site (pBlcat-kB), under expression of wild-type (pc/p210) and kinase inactive mutant (pc/ p210K 7 ) of p210 BCR ± ABL . DA1 cells were cotransfected with reporter and expression vectors, maintained in medium with or without IL-3 for 48 h and then transcriptional activations were analysed. In the presence of IL-3 (Figure 1a ), wild-type p210 BCR ± ABL produced a 3.5-fold stimulation in transcription from pBLCAT-kB which was increased (7.5-versus 3.5-fold) in the absence of IL-3 (Figure 1b ). pBLCAT-TRE reporter vector was used as speci®city control. In the presence of IL-3, a low stimulation (1.4-fold) from this promoter was observed in cells expressing wild-type p210 BCR ± ABL protein ( Figure 1a ). This stimulation may be attributed to cell proliferation state since, in contrast to NF-kB, it was not seen in the absence of IL-3 (Figure 1b ) where cells were not proliferating.
In order to con®rm that increased NF-kB activity was inherent to p210 BCR ± ABL expression, a kinase inactive mutant was used. No eect was produced by the p210 BCR ± ABL mutant on transcription from pBLCAT-kB (Figure 1 ). These results revealed that p210 BCR ± ABL protein increased speci®cally NF-kB activity in DA1 cells and required tyrosine kinase activity to mediate this eect.
Characterization of the REL/NF-kB complex(es)
To characterize the REL/NF-kB complex(es), DA1 cell lines constitutively expressing p210 BCR ± ABL were generated by introducing pcDNA-p210 vector. Expression of p210 BCR ± ABL enables IL-3-independent growth of various hematopoietic cell lines (Daley and Baltimore, 1988; Mandanas et al., 1992) . Therefore, we studied DA1 cell viability in the absence of IL-3 following their transfection with vector alone or expressing either wildtype or kinase inactive form of p210 BCR ± ABL . Only cells transfected with wild-type p210 BCR ± ABL , survived and evolved to IL-3-independent proliferating state within 11 days (not shown). These results proved that the IL-3 requirement for DA1 cells was abrogated by p210 BCR ± ABL protein with a functional tyrosine kinase activity. To avoid clonal variation, transfected DA1 cells have been selected following limiting dilution by two procedures: removal of IL-3 or G418 addition. Individual clones arisen from each selection, within 2 weeks after transfection, were expanded in medium without IL-3 and immediately analysed for p210 BCR ± ABL expression by immune tyrosine kinase assay (data not shown). The highest expressing clone from each selection, 11a (IL-3
7
) and 3b (G418), was retained for further studies.
Transcriptional activation assay was undertaken in transformed DA1 cells. Like parental cells supplemented with Il-3, the IL-3-independent transformed cells showed strong activation of kB reporter construct compared to IL-3 deprived parental DA1 cells (data not shown). However, this study did not allow distinction between transcriptional activation inherent to p210 BCR ± ABL expression and the one due to cellular proliferation state. Therefore, we had recourse to EMSA was performed by incubating nuclear extracts with the kB consensus site. As shown in Figure 2a , a speci®c complex (arrow A) was detected with parental DA1 nuclear extracts (lanes 1 ± 3). The same complex A, without signi®cant quantitative dierence, was observed with nuclear extracts of transformed cells. But unlike the parental cells, transformed cells showed an additional speci®c complex (arrow B, lanes 4 ± 6). With the oct-1 probe (Staudt et al., 1986) used as control, no dierence was observed between parental and transformed DA1 cells (Figure 2b , lanes 1 and 2, respectively). Of note, the nature of the slowest migrating complex (Figure 2a) is unknown, its formation was not reproducible with the same nuclear extracts.
To identify the NF-kB members present in the two distinct complexes, speci®c antibodies were used in supershift assays (Figure 3 ). The common lower complex was shifted by anti-p50 antibody but by neither anti-p65 nor anti-c-Rel antibodies. The upper complex detected speci®cally in transformed DA1 cells was shifted only by anti-p65 antibody. We concluded that the two complexes contained p50 and p65 NF-kB subunits, respectively.
These results revealed the presence of p65 NF-kB DNA binding activity in transformed DA1 cell lines suggesting that p210 BCR ± ABL may activate p65 protein.
Analysis of p65 NF-kB protein and mRNA levels
To determine how p65 was activated in p210 BCR ± ABL transformed DA1 cell lines, we ®rst analysed the p65 protein expression and its subcellular distribution. For this purpose, cells were metabolically labeled, cytoplasmic and nuclear extracts were prepared, and then separately subjected to sequential immunoprecipitation using speci®c anti-p65 antibody. This analysis revealed ( Figure 4a ) a low detectable p65 protein in parental DA1 cells (lanes 2 and 5), while in transformed cells, p65 protein was highly present in cytoplasmic extract (lane 3) and to a lesser extent in the nuclear extract (lane 6). These results showed that parental and transformed DA1 cells diered in p65 protein levels. Therefore, p65 activation in transformed DA1 cells could mainly not be attributed to nuclear translocation. Then, we analysed p65 mRNA levels in parental and transformed cells by Northern blot. No quantitative dierence in p65 transcripts was shown between the two cell lines (Figure 4b ). Data indicated that activation of p65 NF-kB by p210
BCR ± ABL did not occur at the transcriptional level. 
Analysis of p65 protein stability
Results shown above suggest that p210 BCR ± ABL may activate p65 NF-kB at the translational or posttranslational level, probably by extending its half life. In order to test this hypothesis, pulse-chase experiments were performed. Cells were metabolically labeled for 30 min and cellular extracts were prepared at the indicated times after the labeling end ( Figure 5 ). The half-life of p65 protein in parental DA1 cells was about 5 h while in clones expressing p210 BCR ± ABL the half-life was extended to 24 h ( Figure 5 ). The result suggested that p210 BCR ± ABL protein may activate p65 protein by increasing its stability.
To con®rm that the observed eect was speci®c to p210 BCR ± ABL expression, p65 protein stability was analysed in mass cell populations expressing either wild-type or kinase inactive mutant of BCR ± ABL protein. DA1 cells were transfected with pcDNA-p210 or pcDNA-p210K 7 vectors and then selected using G418 in the presence of IL-3. G418-resistant mass cell populations obtained within 2 weeks after transfection were analysed for BCR ± ABL protein expression and for the loss of tyrosine kinase activity in the mutant form (not shown). P65 protein stability was then analysed. Cells expressing wild-type p210 BCR ± ABL showed the same increased half-life of p65 protein as isolated clones tested above: 24 h ( Figure 5 ) indicating that the observed eect was not a result of clonal variability. In cell population expressing p210 BCR ± ABL kinase inactive mutant, as in control parental DA1 cells, the half-life of p65 protein was about 5 h ( Figure 5 ).
These results clearly demonstrated that p210 BCR ± ABL increases p65 protein stability, and that it required a functional tyrosine kinase activity to mediate this eect.
Eect of p65 NF-kB expression inhibition of p210
Oligonucleotide antisense experiments were performed in order to determine p65 protein function in p210 BCR ± ABL mediated transformation. The eect of antisense oligonucleotides on p65 expression was ®rst veri®ed. Cells (clone 3b) were plated and treated with modi®ed phosphorothioate oligonucleotides for 48 h and their total RNA were analysed by RT ± PCR ( Figure 6 ). The addition of p65 antisense oligonucleotide induced a potent inhibition (at least 15-fold) of p65 mRNA level (lane 2) compared to the sense of parental DA1 cells (lane 1) and of clones expressing BCR ± ABL protein (lanes 2 and 3 for clones 3b and 11a respectively) were resolved on denaturing formaldehyde 1% agarose and were hybridized after blotting with p65 NF-kB probe (the 932 bp random labeled EcoRI fragment from human cDNA). bactin expression was tested in the same samples as control Figure 5 Pulse-chase experiment. Cells were starved in methionine/cysteine free-medium for 30 min, and pulse labeled for 30 min. Cells were then washed and seeded at 3610 6 cells per plate in normal medium. Lysates from separate plates were prepared at the indicated times (in hours). An equal volume of each lysate was immunoprecipitated using p65-antibody (1 mg/ml) followed by electrophoresis on 15% SDS-polyacrylamide gel and uorography. p65 protein was quantitated by PhosphorImager, and the data were plotted against time of chase. . Also the speci®c eect of antisense oligonucleotide on p65 NF-kB expression was con®rmed using transcriptional activation assays. In transformed cells (3b clone), as shown in Table 1 , antisense oligonucleotide did not change the CAT activity from pBLCAT2 while a signi®cant reduction of transcriptional activation from pBLCAT-kB (1.8 vs 5.2) was obtained. This result demonstrated the speci®c eect of the p65 antisense oligonucleotide. The p65 expression inhibition eect was then analysed on p210 BCR ± ABL mediated transformation. DA1 cells were transfected either with vector alone or expressing p210 BCR ± ABL and seeded, following IL-3 withdrawal, at the same density, in the presence of oligonucleotides that were sense, antisense or reverse (R)-antisense to p65 NF-kB. Two weeks later, the number of arisen clones was counted. Data shown in Table 1 indicated that DA1 cells transfected with vector alone did not survive IL-3 removal. Conversely, p210 BCR ± ABL transfected cells have given rise to 40 IL-3-independent clones (0.4% of total cell number) and to 21 and 25 clones when treated with sense and Rantisense oligonucleotides, respectively, but no cloned was observed after treatment with oligonucleotide antisense to p65. The data suggested that antisense oligonucleotides interfered with p210 BCR ± ABL transforming activity. In order to con®rm the speci®city of this eect, the same experiment was performed by incubating pcDNA-p210 transfected cells with IL-3 and analysing oligonucleotide eects on G418 resistant clones. Results shown in Table 1 revealed no dierence in the number of G418-resistant clones between sense, antisense and R-antisense oligonucleotide treatments. The same results were obtained for pcDNA3 transfected DA1 cells while no clones arose from non-transfected cells (not shown). These results allowed us to conclude that p65 antisense interfered speci®cally with p210 BCR ± ABL induced transformation. We next investigated the eect of p65 antisense oligonucleotides on cellular growth of IL-3-independent transformed DA1 cells (Table 2) . Analysis was ®rst performed with 3b clone by treating cells once with or without p65 oligonucleotides and counting their number 1 week later. No signi®cant eect was observed since the same cell number was seen after treatment with sense and antisense oligonucleotides. Taking the increased stability of p65 protein into account, antisense experiment was performed by renewing oligonucleotide treatment every 2 days. In this case, a 38% inhibition of cell number was observed by p65 antisense. Furthermore, antisense treatment of clone 10a which expressed lower p210 BCR ± ABL level than clone 3b showed a 54% inhibition of cell number. These experiments revealed that p65 antisense inhibited growth of p210 BCR ± ABL transformed DA1 cells.
Discussion
The present study was undertaken to investigate whether REL/NF-kB family is involved in p210 BCR ± ABL induced transformation. DA1, an IL-3-dependent Transfected DA1 cells were plated at the same density (10 4 cells) with oligonucleotides after IL-3 removal, or after G418 addition in the presence of IL-3. Results indicate the number of clones arisen within 2 weeks, which are IL-3-independent or G418-resistant. Results shown are representatives of 3 independent experiments. b Transformed 3b cells were transfected with pBLCAT2 or pBLCAT-kB and plated with oligonucleotides. CAT activities were determined 48 h after transfection. Cells from clone 3b and clone 10a (10 4 cells) were plated with oligonucleotides whose addition in medium was renewed every 2 days, and cell number was analysed after 1 week. Results shown are representatives of 3 independent experiments P210 BCR ± ABL activates p65 NF-kB M Hamdane et al murine progenitor myeloid cell line, has been used as model system. Transcriptional activation assays revealed a speci®c increase in NF-kB activity following p210 BCR ± ABL expression. This result is of interest since REL/NF-kB activity is targeted by numerous oncogenes and its deregulation is involved in malignant transformation (Gilmore et al., 1996) . Moreover NF-kB activity is targeted by v-abl, its down regulation allows transformation of B lineage precursors (Kerr, 1994; Klug et al., 1994) . The dierence with our results can be attributed to the fundamental dierences between BCR ± ABL and v-abl regarding to their structure, their cellular localization, their transforming potential in ®broblasts, their interaction with signaling proteins and the induced disease in vivo (Cook, 1982; Daley et al., 1987 Daley et al., , 1990 McWhirter and Witte, 1991; McWhirter et al., 1993; Reuther et al., 1994; Varticovski et al., 1991) . In addition, inhibition of NF-kB activity by v-abl can only be restricted to pre-B cells and the v-abl tyrosine kinase since NF-kB activity is dierentially regulated depending on the cell type and the involved stimuli (Brown et al., 1994; Lernbecher et al., 1993; Shu et al., 1993) .
EMSAs and antibody supershift assays were performed to identify the activated REL/NF-kB members. Data suggested that p210 BCR ± ABL activates p65 subunit since its DNA binding activity has been found in DA1 cells expressing the chimeric protein but not in parental cells (Figures 4 and 5) . However, this results does not rule out the activation of other REL/ NF-kB family subunits. Indeed, the members of this family have dierent anities for various DNA binding motifs and each subunit combination may have optimal motifs (Fujita et al., 1992; Kunsch et al., 1992; Narayanan et al., 1993) . In the present study, we used the representative Igk kB motif (mouse immunoglobulin k chain) which probably can not display all REL/NF-kB subunit dimers prominently. However, the level of nuclear p65 protein detected in DA1 cells expressing p210 BCR ± ABL may have a considerable signi®cance since some genes are regulated by optimal kB motifs which are more responsive for p65 protein (Kunsch et al., 1992) .
The presence of p65 DNA binding in p210 BCR ± ABL transformed DA1 cells can result from regulation of p65 protein at dierent levels including DNA-binding, nuclear translocation or expression. Analysis of cellular distribution of p65 protein (Figure 4 ) did not reveal its presence in either cytoplasmic or nuclear extracts from parental DA1 cells, unlike transformed cells. This results suggested that p210 BCR ± ABL may regulated p65 protein at expression level. Further experiments (see Northern blot and pulse-chase data) showed that BCR ± ABL activate p65 protein by extending its half-life and that an active tyrosine kinase activity is required to mediate this eect. Biochemical mechanisms by which p210 BCR ± ABL increases p65 protein stability remains to be elucidated. P65 protein has been found phosphorylated after induction in vivo and it was suggested that this phosphorylation could aect p65 activity at dierent levels such as elevating its DNA binding anity (Naumann and Scheidereit, 1994) . Likewise, it has been reported that tyrosine kinases could be implicated in the regulation of REL/NF-kB family of transcription factors (Neumann et al., 1992) .
Finding that p65 protein is activated by p210 BCR ± ABL is interesting since p65 subunit has been involved in the transformation process of various cells and plays a critical role in the regulation of cell adhesion molecules Perez et al., 1994; Shu et al., 1993; Sokoloski et al., 1993) . Indeed, antisense to p65 leads to inhibition of tumor cell growth and regression of established tumors by interfering with cellular adhesion molecules Kitajima et al., 1992) . Likewise, several reports support the interference of p210 BCR ± ABL with an adhesion-mediated transduction pathway. It has been shown that p210 BCR ± ABL abrogates the anchorage requirement for cell proliferation (Renshaw et al., 1995) . Moreover, p210 BCR ± ABL has been found concentrated in structures related to focal adhesion, believed to be a site at which integrin function is regulated (Grumbiner, 1996; Hynes, 1992) , where it induces tyrosine phosphorylation of several focal adhesion proteins and alters their proteinprotein interactions (Salgia et al., 1995a,b,c) . These data suggest a possible interference of p210 BCR ± ABL with an integrin signaling pathway, probably implicated in cell survival (Ruoslahti and Reed, 1994) . Recently, Bazzoni et al. (1996) showed stimulation of integrin function by p210 BCR ± ABL . Our results from antisense oligonucleotides experiments showed that p210 BCR ± ABL transfected DA1 cells treated with antisense to p65 failed to survive after IL-3 removal. Likewise, p65 antisense treatment of transfected DA1 cells lead to cellular growth inhibition. These results suggested that p65 protein is involved in p210 BCR ± ABL mediated transformation. The anti-apoptotic activity assigned to p65 (Beg et al., 1995) led us to speculate that p65 activation is probably an important p210 BCR ± ABL mediated early event and takes part in the p210 BCR ± ABL anti-apoptotic eect.
Together with a recent ®nding (Neumann et al., 1996) showing that p210 BCR ± ABL modulates c-Rel responsiveness to inducers of dierent signaling pathways, the present study is a ®rst report suggesting a possible involvement of REL/NF-kB family in BCR ± ABL mediated transformation. Further studies will be required to investigate the precise role of REL/NF-kB factors in particular p65 protein in p210 BCR ± ABL transformation.
Materials and methods
Plasmids
Reporter vector pBLCAT-kB was obtained by inserting ®ve repeats of oligonucleotide containing the representative kB consensus site: Igk kB (murine immunoglobulin k chain) in the BamHI site of pBLCAT2 reporter vector (Luckow and Shultz, 1987) . The orientation and copy number of kB sites were determined by sequencing.
Expression vector pcDNA-p210 was obtained by cloning the p210 BCR ± ABL cDNA (EcoRI ± SpeI (nt: 585 ± 6778) fragment) from pSP65BCR ± ABL plasmid (Lifshitz et al., 1988) into the EcoRI ± XbaI sites of the pcDNA3 expression vector (In vitrogen, UK).
The kinase inactive p210 BCR ± ABL mutant (defective ATPbinding site) was prepared by oligonucleotide directed mutagenesis (Altered Sites Mutagenesis System from Promega) where the lysine (AAC codon) at position 1172 of wild-type p210 BCR ± ABL was changed to arginine (CGC codon). Mutated cDNA like the wild-type was cloned into the EcoRI ± XbaI sites of the pcDNA3 to obtain pcDNA-p210K 7 vector.
PBLCAT-TRE (Angel et al., 1987) was derivated by inserting the 18 bp collagenase TRE oligonucleotide, which contain the binding site for AP-1 factor, between HindIII and BamHI sites of pBLCAT2. This reporter construct is activated following TPA treatment.
Electroporation and CAT assay
Electroporation DA1 cells (5610 6 ) in exponential growth were suspended in 500 ml of RPMI, mixed with DNA and electroporated at 270 V, 1500 mF (Eurogentec, Easy Ject+), then resuspended in 10 ml of RPMI containing 10% of fetal calf serum (FCS) with or without 2 ng/ml of recombinant murine interleukin-3 (IL-3, Santa Cruz Biotechnology USA).
CAT assay Transfected cells were harvested 48 h later, enzymatic reaction was carried out as described (Gorman et al., 1982) and quanti®ed using a PhosphorImager (Molecular Dynamics Inc.).
Cell culture
Cells DA1 is an IL-3-dependent murine myeloid progenitor cell line (Ihle, 1985) . Cells were grown in RPMI medium with 10% FCS, supplemented with IL-3 (2 ng/ml).
Transformed DA1 clones were obtained as follows Four hours after electroporation, cells were seeded into two 24-well plates (limiting dilution). Forty-eight hours later, cells were subjected to two dierent selection procedures: in one plate, the cells were washed three times to remove IL-3 and then cultured in an IL-3-free medium whereas in the second plate, G418 was added (1 mg/ml) and the cells were maintained with IL-3. Individual clones from each selection were isolated 2 weeks later and were expanded in IL-3-free medium for further studies.
Stable mass cell population expressing BCR ± ABL proteins Forty-eight hours post-electroporation DA1 cells were incubated with G418 in the presence of IL-3. G418 resistant mass cells were obtained within 2 weeks and immediately used for analysis.
Immune complex kinase assay
Cells (3610 6 ) were suspended in 1 ml of kinase lysis buer: 1% Triton X-100, 0.5% sodium dodecyl sulfate, 10 mM Na 2 HPO 4 -NaH 2 HPO 4 (pH 7.4), 150 mM NaCl, 5 mM EDTA, with protease inhibitors (Konopka and Witte, 1985) and incubated 10 min on ice. Cell extracts were clari®ed by centrifugation at 13 000 g for 1 h. Samples were incubated overnight with 10 ml of monoclonal antiAbl antibody (Ab-3 from Oncogene Science) at 48C. The immune complexes were precipitated using 15 ml of protein A/G-agarose (Pierce). Pellets were washed once with SDS containing lysis buer and twice with SDS-free lysis buer. The kinase reaction assay was carried out for 10 min at room temperature with 10 mCi [g-32 P]ATP in 50 ml of kinase buer (20 mM HEPES (pH 7.2), 100 mM NaCl, 0.1% Triton X-100 and 10 mM MnCl 2 ) as previously described (Li et al., 1988) . The reaction was stopped by adding 1 ml of RIPA buer. Immune complexes were washed three times with RIPA, then separated by electrophoresis on a 8% SDS-polyacrylamide gel (Laemmli, 1970) and results were visualized using a PhosphorImager.
Immunoblotting Cells (3610 6 ) were washed twice with PBS, lysed in sodium dodecyl sulfate sample buer (50 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 5% b-mercaptoethanol) and boiled 5 min. Lysates were clari®ed by centrifugation at 13 000 g for 30 min, were resolved on 8% SDS ± polyacrylamide gels and transferred on Immobilon P membrane (Millipore). Blots were probed with anti-Abl monoclonal antibody: Ab3 (10 mg/ml). Immunoreactive proteins were detected by ECL reagent system (DuPont, NEN).
Cell labeling, cytplasmic and nuclear extracts, immunoprecipitation
Exponentially growing cells (5610 6 cells) were washed twice with methionine/cysteine free DMEM medium (Gibco BRL) and incubated at 378C for 1 h in the same medium supplemented with 5% of dialyzed serum and 3% of glutamine. 360 mCi of cell labeling mix (prox-mix 35 S from Amersham) were added, prior to incubation at 378C for 3 ± 4 h.
Cytoplasmic and nuclear extracts and immunoprecipitations were performed as described (Naumann and Scheidereit, 1994 ) with slight modi®cations. Brie¯y, cells were washed twice with PBS, suspended in 200 ml of buer A containing 0.15% of NP-40, incubated for 10 min on ice and subjected to centrifugation at 1000 g for 10 min. Supernatants were referred to as cytoplasmic extracts. Nuclei in the pellets were lysed in 200 ml of buer C on ice for 10 min and nuclear extracts were clari®ed by centrifugation at 12 000 g for 5 min (Dignam et al., 1983) . Cytoplasmic and nuclear extracts were diluted in four volumes of RIPA, supplemented with protease inhibitors and then immunoprecipitated as described above. The immune complexes were resuspended in 200 ml of denaturing buer (50 mM Tris-HCl, pH 7.5, containing 0.5% SDS, and 70 mM b-mercaptoethanol), boiled 10 min, diluted in 4 volumes of RIPA buer lacking SDS as described (Kovary and Bravo, 1991) and then subjected to a second immunoprecipitation.
Pulse-chase experiment
Exponentially growing cells were washed as described above and incubated at 378C for 30 min in methionine/cysteine free DMEM medium supplemented with 5% of dialyzed serum and 3% of glutamine (5610 6 cell/ml). Cell labeling mix (prox-mix 35 S) was added (350 mCi/ml) for 30 min. At the end of labeling, cells were washed and incubated with standard medium (time 0). 3610 6 cells were lysed, at the subsequent time points, in RIPA buer, disrupted by repeated aspiration through a 21 gauge needle and lysates were clari®ed by centrifugation at 13 000 g for 30 min and then stored at 7708C before immunoprecipitation which was performed as described (Scott et al., 1993) . Immunoprecipitated products were analysed as above.
Electrophoretic mobility shift assay
Nuclear extracts were prepared as previously described (Dignam et al., 1983) . Binding reactions were performed at 308C for 20 min, with 10 000 c.p.m. of 32 P-labeled oligonucleotide probe in 20 ml of reaction mixture containing 10 mg of nuclear extracts, 2 mg of poly(dI-dC)(dI-dC), 300 mg/ml of BSA and 10% of glycerol. For competition experiments, an excess of unlabeled oligonucleotide was added prior to probe. Supershift assays were carried out by preincubating the reaction mixture with 2 mg of Transcruz TM Gel Supershift assay (Santa Cruz Biotechnology) for 30 min at 48C, followed by incubation with the probe for 20 min at 308C. Samples were resolved in a 4% nondenaturing polyacrylamide gel (acrylamide: bisacrylamide 30 : 1) as described .
RNA analysis
Northern blot analysis was performed as previously described (GalieÁ ge-Zouitina et al., 1996) . For PCR analysis, reverse transcriptase polymerase chain reaction (RT ± PCR) was performed as previously described (Sokoloski et al., 1993) . Brie¯y total RNA were prepared using RNazol B (Bioprobe), 1 microgram of total RNA was reverse transcribed into cDNA using random hexamers (Boehringer Mannheim), by M-MLV reverse transcriptase (Gibco BRL). The cDNA was analysed by PCR for 30 cycles (948C, 1 min; 588C, 2 min; 728C, 3 min) in the presence of 1 mCi of [a-32 P]dCTP (3000 Ci/mmol) (Amersham, UK). Reaction products were resolved in an 8% polyacrylamide gel and bands were quanti®ed with a PhosphorImager.
Antisense oligonucleotides DA1 cells were transfected with the expression vectors, washed three times to remove IL-3 and plated (10 5 cells per ml of medium supplemented with heat-inactivated serum) in the presence of phosphorothioate modi®ed oligonucleotides (30 mM). Arisen clones were observed 2 weeks later.
Oligonucleotides
The oligonucleotides were purchased from Eurogentech (Belgium) Kinase inactive mutagenic primer 5'-ACGGTGGCCGTG-CGCACCTTGAAGGAG-3' 
5'-GGAGGAGTCCGGAACACAATGGCCACTTGCC -
3'
GAPDH primers have been described (Narayanan et al., 1992) and de®ne an amplicon of 185 bp:
( 1 )
5'-CCATGGAGAAGGCTGGGG-3'
5'-CAAAGTTGTTGTCATGGATGACC-3' p65 phosphorothioate modi®ed oligonucleotides have been described . S e n s e
5'-ACCATGGACGATCTGTTTCCC-3'
A n t i s e n s e 5'-GGGAAACAGATCGTCCATGGT-3' R -a n t i s e n s e 5'-TGGTACCTGCTAGACAAAGGG-3'
